MC-Val-Cit-PAB-Exatecan

CAS No. 2504068-28-2

MC-Val-Cit-PAB-Exatecan( ——— )

Catalog No. M38011 CAS No. 2504068-28-2

MC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) is a agent-linker conjugate for ADC. MC-Val-Cit-PAB-Exatecan is composed of a DNA topoisomerase I DX-8951 and a cathepsin cleavable ADC linker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 93 In Stock
10MG 155 In Stock
25MG 323 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MC-Val-Cit-PAB-Exatecan
  • Note
    Research use only, not for human use.
  • Brief Description
    MC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) is a agent-linker conjugate for ADC. MC-Val-Cit-PAB-Exatecan is composed of a DNA topoisomerase I DX-8951 and a cathepsin cleavable ADC linker.
  • Description
    MC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) is a agent-linker conjugate for ADC.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Topoisomerase
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    2504068-28-2
  • Formula Weight
    1034.1
  • Molecular Formula
    C53H60FN9O12
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 100 mg/mL (96.70 mM )
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Anish Thomas, et al. Antibody-drug conjugates for cancer therapy. Lancet Oncol. 2016 Jun;17(6):e254-e262.?
molnova catalog
related products
  • Calycosin

    Calycosin (Cyclosin) is a natural active compound with anti-oxidative and anti-inflammation activity.

  • Thymulin

    Thymulin is a peptide hormone which is mainly produced by thymic epithelial cells and it has immune-modulatory and anti-inflammatory effects.

  • Rhaponiticin

    Rhaponticin(Rhaponiticin) can alleviate liver steatosis and improve blood glucose and lipid profiles in KK/Ay diabetic mice, indicates that rhaponticin has a noticeable antidiabetic effect.